Recent insights into the roles played by PPAR ligands have enabled development of PPAR agonists/antagonists, which serve as candidate drugs for inflammatory, metabolic, and autoimmune diseases, as well as cancers [12]. This evidence concerns the gene PPARA and autoimmune disease.